Johnson & Johnson (JNJ) reported late-stage clinical trial results showing that adding its prostate cancer drug apalutamide to hormone therapy before and after surgery improved outcomes for men with ...
1hon MSN
Johnson & Johnson prostate cancer drug reduces risk of cancer spread and death in late-stage study
The study, which followed patients for over five years, found that those who received the regimen were nine times more ...
Thousands of men with advanced prostate cancer could soon live longer thanks to a treatment which cuts the risk of the ...
A previous trial involving patients with metastatic prostate cancer that was resistant to androgen pathway modulation (formerly referred to as castration-resistant) showed that adding talazoparib ...
Radical prostatectomy is potentially curative in patients with high-risk localized or locally advanced prostate cancer; however, relapse occurs within 5 years in up to 50% of patients. We conducted a ...
Former first lady Jill Biden opened up about her husband’s battle with prostate cancer in a new interview. She said in a ...
Apollo Hospitals Chennai, a leader in robotic-assisted cancer care, has performed the world's first Video Endoscopic Inguinal Lymphadenectomy (VEIL) using the Hugo Robotic-Assisted Surgery (RAS) ...
Researchers found that women who had undergone colorectal adenoma resection still showed gut microbiome and fecal metabolome ...
Siemens Healthineers’ MRI scanners would guide robotic neurosurgeries performed with AiM’s platform. Elsewhere, Procept ...
Researchers at Columbia University Irving Medical Center have identified a gene that drives the development of neuroendocrine ...
UK National Screening Committee rejects call from Olympic legend Sir Chris Hoy to offer PSA test to all men at higher risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results